REBECCA MAUREEN HOWELL to Neoplasms, Radiation-Induced
This is a "connection" page, showing publications REBECCA MAUREEN HOWELL has written about Neoplasms, Radiation-Induced.
Connection Strength
1.546
-
Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation Therapy. Radiat Res. 2023 10 01; 200(4):331-339.
Score: 0.192
-
Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER Cohorts. J Clin Oncol. 2021 09 20; 39(27):3012-3021.
Score: 0.163
-
Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Radiat Res. 2020 02; 193(2):95-106.
Score: 0.147
-
Genome-Wide Association Study in Irradiated Childhood Cancer Survivors Identifies HTR2A for?Subsequent Basal Cell Carcinoma. J Invest Dermatol. 2019 09; 139(9):2042-2045.e8.
Score: 0.140
-
Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer. J Natl Cancer Inst. 2017 11 01; 109(11).
Score: 0.128
-
Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study. Br J Cancer. 2017 Jul 11; 117(2):290-299.
Score: 0.124
-
Risk-optimized proton therapy to minimize radiogenic second cancers. Phys Med Biol. 2015 May 21; 60(10):3999-4013.
Score: 0.107
-
A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation. Radiother Oncol. 2014 Oct; 113(1):84-8.
Score: 0.102
-
Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient. Phys Med Biol. 2013 Feb 21; 58(4):807-23.
Score: 0.092
-
Impact of margin size on the predicted risk of radiogenic second cancers following proton arc therapy and volumetric modulated arc therapy for prostate cancer. Phys Med Biol. 2012 Dec 07; 57(23):N469-79.
Score: 0.090
-
Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer. Phys Med Biol. 2012 Nov 07; 57(21):7117-32.
Score: 0.090
-
Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma. Phys Med Biol. 2010 Dec 07; 55(23):7055-65.
Score: 0.079
-
Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort. J Clin Oncol. 2019 12 01; 37(34):3310-3319.
Score: 0.037
-
Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015. JAMA. 2017 02 28; 317(8):814-824.
Score: 0.030
-
Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: an international population-based study of 414 patients. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):694-701.
Score: 0.023